ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

BRMS1L suppresses breast cancer metastasis by inducing epigenetic silence of FZD10

Gong Chang; Qu Shaohua; Lv Xiao Bin; Liu Bodu; Tan Weige; Nie Yan; Su Fengxi; Liu Qiang; Yao Herui; Song Erwei*
Nature Communications2014-11DOI: 10.1038/ncomms6406
70被引8阅读
引用收藏
分享

摘要

BRMS1L (breast cancer metastasis suppressor 1 like, BRMS1-like) is a component of Sin3A-histone deacetylase (HDAC) co-repressor complex that suppresses target gene transcription. Here we show that reduced BRMS1L in breast cancer tissues is associated with metastasis and poor patient survival. Functionally, BRMS1L inhibits breast cancer cells migration and invasion by inhibiting epithelial-mesenchymal transition. These effects are mediated by epigenetic silencing of FZD10, a receptor for Wnt signalling, through HDAC1 recruitment and histone H3K9 deacetylation at the promoter. Consequently, BRMS1L-induced FZD10 silencing inhibits aberrant activation of WNT3-FZD10-beta-catenin signalling. Furthermore, BRMS1L is a target of miR-106b and miR-106b upregulation leads to BRMS1L reduction in breast cancer cells. RNA interference-mediated silencing of BRMS1L expression promotes metastasis of breast cancer xenografts in immunocompromised mice, whereas ectopic BRMS1L expression inhibits metastasis. Therefore, BRMS1L provides an epigenetic regulation of Wnt signalling in breast cancer cells and acts as a breast cancer metastasis suppressor.

被引文献 (1)相关
加载中…
  • The network of non-coding RNAs and their molecular targets in breast cancer
    Francesca, Crudele; Nicoletta, Bianchi; Eva, Reali; Marco, Galasso; Chiara, Agnoletto; Stefano, VoliniaMolecular Cancer, 2020, 19(1): 61.被引 6

发表信息

论文状态
公开发表
期刊
Nature Communications
发表日期
2014-11
卷期
第 5 卷
页码
5406
DOI
10.1038/ncomms6406
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q1
成果收录
SCI
资助标注
973 Projects from Ministry of Science and Technology of China [2010CB912800, 2011CB504203]; Natural Science Foundation of China [81230060, 81261140373, 81272893, 81102023, 81372819, 81272894, 81472466]; Specialized Research Fund for the Doctoral Program of Higher Education [20120171110075]; Program for New Century Excellent Talents in University [NCET-12-0565]; Science Foundation of Guangdong Province [S2012030006287]; Guangdong Department of Science & Technology Translational Medicine Center grant [2011A080300002]; Guangzhou Science and Technology Bureau [2012J2200092, 2014J4100170]; Sun Yat-sen University Training Project [11ykpy28, 12ykpy32, 13ykzd14]; Special Project on New Drug Innovation of Sun Yat-sen University; Yat-Sen Scholarship for Young Scientist and Translational medicine public platform of Guangdong Province [4202037]; Key Laboratory of Malignant Tumor Gene Regulation and Target Therapy of Guangdong Higher Education Institutes, Sun Yat-Sen University [KLB09001]; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [163]

作者

  • G

    Gong Chang (第一作者)

  • Q

    Qu Shaohua

查看全部 10 位作者收起作者
  • L

    Lv Xiao Bin

  • L

    Liu Bodu

  • T

    Tan Weige

  • N

    Nie Yan

  • S

    Su Fengxi

  • L

    Liu Qiang

  • Y

    Yao Herui

  • S

    Song Erwei (通讯)

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417